What Is Tirzepatide?
Tirzepatide RESEARCH
It has shown encouraging results in preliminary investigations, which may thrill doctors who treat obese patients. Throughout a 26-week study, those who took Tirzepatide lost an average of 11% of their body weight, while those who took a placebo lost an average of 2.5%. Tirzepatide has also been proven to benefit glycaemic management, blood pressure, and cholesterol. The participants took a maximum tolerated dose of tirzepatide for 36 weeks, which yielded the expected weight reduction of 20.9 percent with improvements in blood pressure, blood sugar metrics and lipid levels.
How Does Tirzepatide Work?
What Is The Function Of Tirzepatide?
You will receive a syringe with Tirzepatide. The Tirzepatide is to be used once weekly. The medicine can be injected into the upper arm, thigh, or abdomen. It is most effective when stored at a cool (36°F to 46°F) temperature.
How Often Should Tirzepatide Be Taken?
What Are Tirzepatide Side Effects?
Does The Food And Drug Administration Approve Tirzepatide For Weight Loss?
Tirzepatide, sold under the brand Mounjaro/Zepbound, has been approved by the FDA for treating type 2 diabetes and BMI>30. Adults with diabetes can use this drug to treat life-threatening hypoglycemia (low blood sugar). Tirzepatide may not be an appropriate or safe option for all patients.
Tirzepatide Or Semaglutide: Which Is More Effective?
Tirzepatide and Semaglutide are both medications being studied for their potential to promote weight loss. While both drugs work by activating GLP-1 receptors to increase insulin secretion and reduce appetite, there are differences in how they are administered and their potential side effects. Tirzepatide is a medication that is administered once weekly by subcutaneous injection. Early clinical trials have shown that it may promote weight loss of up to 15-21%.
Who Should Not Use Tirzepatide?
Those with a family history of medullary thyroid cancer (MTC) or MENS Type 2 (MEN 2). Those with a history of MTC or MEN 2 should avoid taking tirzepatide because of the drug’s link to an increased risk of thyroid cancers in animal studies.
Those who suffer from severe cases of digestive difficulties or motility issues. The gastrointestinal side effects of tirzepatide include nausea, vomiting, and diarrhea. These adverse effects may more likely occur in people with a severe gastrointestinal illness or motility difficulties. Those who have serious kidney damage. Those with severe renal impairment may be at a higher risk for side effects from tirzepatide because the drug is flushed out of the body via the kidneys.
We’re about full transparency, honesty, and developing genuine and trusting relationships with our clients. Welcome to La Bella Vida.
MESSAGE US
Get in Touch